CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2009, Vol.15 (19), p.6052-6061
Hauptverfasser: GOVINDAN, Serengulam V, CARDILLO, Thomas M, MOON, Sung-Ju, HANSEN, Hans J, GOLDENBERG, David M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6061
container_issue 19
container_start_page 6052
container_title Clinical cancer research
container_volume 15
creator GOVINDAN, Serengulam V
CARDILLO, Thomas M
MOON, Sung-Ju
HANSEN, Hans J
GOLDENBERG, David M
description
format Article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_22044290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22044290</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_220442903</originalsourceid><addsrcrecordid>eNqNjM2KwjAURoOMoKO-w924DKRp6s9SguJiZhDswp1c622ttElJUqQ-_WQxDzCr73xwOCM2TbJszVO5yj4ii_WGC5XKCfv0_ilEohKhpmzQ-53efWc8R1dRoDvkD3LYDWBLOPYtGtC2saYuAM0dTmgKRxji1RHJwYWMrRyWwcOrDg842UAmwBfeKPTvGLjx8w9PN9C0bW9sYc2zrzCQn7NxiY2nxd_O2PKwz_WRd-gLbEoX-7W_dq5u0Q1XKYVScivS_3q_PQRQGg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><creator>GOVINDAN, Serengulam V ; CARDILLO, Thomas M ; MOON, Sung-Ju ; HANSEN, Hans J ; GOLDENBERG, David M</creator><creatorcontrib>GOVINDAN, Serengulam V ; CARDILLO, Thomas M ; MOON, Sung-Ju ; HANSEN, Hans J ; GOLDENBERG, David M</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>CODEN: CCREF4</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Gastroenterology. Liver. Pancreas. Abdomen ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Medical sciences ; Pharmacology. Drug treatments ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Clinical cancer research, 2009, Vol.15 (19), p.6052-6061</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22044290$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>GOVINDAN, Serengulam V</creatorcontrib><creatorcontrib>CARDILLO, Thomas M</creatorcontrib><creatorcontrib>MOON, Sung-Ju</creatorcontrib><creatorcontrib>HANSEN, Hans J</creatorcontrib><creatorcontrib>GOLDENBERG, David M</creatorcontrib><title>CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates</title><title>Clinical cancer research</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNjM2KwjAURoOMoKO-w924DKRp6s9SguJiZhDswp1c622ttElJUqQ-_WQxDzCr73xwOCM2TbJszVO5yj4ii_WGC5XKCfv0_ilEohKhpmzQ-53efWc8R1dRoDvkD3LYDWBLOPYtGtC2saYuAM0dTmgKRxji1RHJwYWMrRyWwcOrDg842UAmwBfeKPTvGLjx8w9PN9C0bW9sYc2zrzCQn7NxiY2nxd_O2PKwz_WRd-gLbEoX-7W_dq5u0Q1XKYVScivS_3q_PQRQGg</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>GOVINDAN, Serengulam V</creator><creator>CARDILLO, Thomas M</creator><creator>MOON, Sung-Ju</creator><creator>HANSEN, Hans J</creator><creator>GOLDENBERG, David M</creator><general>American Association for Cancer Research</general><scope>IQODW</scope></search><sort><creationdate>2009</creationdate><title>CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates</title><author>GOVINDAN, Serengulam V ; CARDILLO, Thomas M ; MOON, Sung-Ju ; HANSEN, Hans J ; GOLDENBERG, David M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_220442903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GOVINDAN, Serengulam V</creatorcontrib><creatorcontrib>CARDILLO, Thomas M</creatorcontrib><creatorcontrib>MOON, Sung-Ju</creatorcontrib><creatorcontrib>HANSEN, Hans J</creatorcontrib><creatorcontrib>GOLDENBERG, David M</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GOVINDAN, Serengulam V</au><au>CARDILLO, Thomas M</au><au>MOON, Sung-Ju</au><au>HANSEN, Hans J</au><au>GOLDENBERG, David M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates</atitle><jtitle>Clinical cancer research</jtitle><date>2009</date><risdate>2009</risdate><volume>15</volume><issue>19</issue><spage>6052</spage><epage>6061</epage><pages>6052-6061</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><coden>CCREF4</coden><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2009, Vol.15 (19), p.6052-6061
issn 1078-0432
1557-3265
language eng
recordid cdi_pascalfrancis_primary_22044290
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research; Alma/SFX Local Collection
subjects Antineoplastic agents
Biological and medical sciences
Gastroenterology. Liver. Pancreas. Abdomen
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Medical sciences
Pharmacology. Drug treatments
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumors
title CEACAM5-Targeted Therapy of Human Colonic and Pancreatic Cancer Xenografts with Potent Labetuzumab-SN-38 lmmunoconjugates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CEACAM5-Targeted%20Therapy%20of%20Human%20Colonic%20and%20Pancreatic%20Cancer%20Xenografts%20with%20Potent%20Labetuzumab-SN-38%20lmmunoconjugates&rft.jtitle=Clinical%20cancer%20research&rft.au=GOVINDAN,%20Serengulam%20V&rft.date=2009&rft.volume=15&rft.issue=19&rft.spage=6052&rft.epage=6061&rft.pages=6052-6061&rft.issn=1078-0432&rft.eissn=1557-3265&rft.coden=CCREF4&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E22044290%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true